Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Comparison of health technology assessment for new medicines in France and England : an example based on ixazomib for patients with relapsed or refractory multiple myeloma

Tools
- Tools
+ Tools

Armoiry, Xavier, Spath, Hans-Martin, Clarke, Aileen, Connock, Martin, Sutcliffe, Paul and Dussart, Claude (2019) Comparison of health technology assessment for new medicines in France and England : an example based on ixazomib for patients with relapsed or refractory multiple myeloma. Journal of Market Access & Health Policy, 7 (1). 1648971. doi:10.1080/20016689.2019.1648971 ISSN 2001-6689.

[img]
Preview
PDF
WRAP-Comparison-health-technology-medicines-France-England-Clarke-2019.pdf - Published Version - Requires a PDF viewer.
Available under License Creative Commons: Attribution-Noncommercial 4.0.

Download (915Kb) | Preview
Official URL: https://doi.org/10.1080/20016689.2019.1648971

Request Changes to record.

Abstract

Introduction: The appraisal of medicines is often a complex and iterative process. We compared the health technology assessment (HTA) process in England and France taking as a case study the example of ixazomib for multiple myeloma.

Methods: We undertook an analysis of eight relevant published documents identifed from the websites of the French and English HTA bodies (HAS and NICE, respectively). We analyse patients’ availability of ixazomib resulting in the different stages of the appraisal process.

Results: We identified differences in the assessment, one of these being the use of an appraisal scope in England allowing the differentiation of populations and comparators according to previously approved treatments. Ixazomib became available earlier in France as part of an early access programme, but the availability was soon discontinued for newly eligible patients following an HAS determination that Ixazomib yielded no additional benefit. This opinion resulted in long pricing discussions. In England, despite the absence of an early access programme and following a process that included cost-effectiveness evaluation combined with pricing discussions, the medicine was fairly rapidly recommended for use.

Conclusions: Differences in the HTA process may result in appreciable differences in time from marketing authorisation to health service adoption of newly licensed drugs

Item Type: Journal Article
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences > Population, Evidence & Technologies (PET)
Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
SWORD Depositor: Library Publications Router
Library of Congress Subject Headings (LCSH): Medical technology -- Evaluation -- England, Medical technology -- Evaluation -- France, Multiple myeloma , Multiple myeloma -- Treatment
Journal or Publication Title: Journal of Market Access & Health Policy
Publisher: Informa UK Limited
ISSN: 2001-6689
Official Date: 30 July 2019
Dates:
DateEvent
30 July 2019Published
22 July 2019Accepted
Volume: 7
Number: 1
Article Number: 1648971
DOI: 10.1080/20016689.2019.1648971
Status: Peer Reviewed
Publication Status: Published
Reuse Statement (publisher, data, author rights): ** Article version: VoR ** From Crossref via Jisc Publications Router ** History: epub 30-07-2019. ** Licence for VoR version of this article starting on 01-01-2019: http://creativecommons.org/licenses/by-nc/4.0/
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 12 August 2019
Date of first compliant Open Access: 12 August 2019
Related URLs:
  • http://creativecommons.org/licenses/by-n...

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us